We have seen three issues so far since yesterday’s close to sell shares of stock and one offering still pending on the calendar for the week. We have seen filings out of Ormat Technologies Inc. (NYSE: ORA), Texas Capital Bancshares, Inc. (NASDAQ: TCBI), and Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX). We are also still waiting for pricing from Otter Tail Corp. (NASDAQ: OTTR) on its secondary offering.
Ormat Technologies Inc. (NYSE: ORA) filed last night for a universalshelf registration of up to $1.5 Billion in mixed securities. Itscurrent market cap is $1.69 Billion and as of June 30 it had $709.79million in total liabilities. There are no indications pre-market onthis stock.
Texas Capital Bancshares, Inc. (NASDAQ: TCBI) has filed for existingshareholders to sell up to 4,000,000 shares of common stock. Allshares will be sold by selling shareholders and the company willreceive none of the proceeds from the sale of stock. It will have over30.8 million shares outstanding after this offering. Shares closed at$18.89 yesterday and have not traded this morning before the open. Wewould note that the reason this isn’t an impact is because earlier thismonth the company sold these shares to T. Rowe Price (NASDAQ: TROW)funds and these are those shares.
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) announced last nightthat it was going to sell 7 million shares of common stock subject tomarket conditions via Goldman Sachs. It priced its offering with moreshare at 7.5 million shares for a price of $25.50. Shares are tradingdown 4%at $25.50 and the 52-week trading range is $13.84 to $40.10.
Otter Tail (NASDAQ: OTTR) has already filed to sell 5 million shares ofcommon stock and we were expecting that to come this week. As of thismorning we have not seen a pricing nor any color on how the currentmarket meltdown will play into this.
Jon C. Ogg
September 18, 2008
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
